论文部分内容阅读
本文对42例肺癌骨转移患者及其不同病理类型的关系进行分析,并对肺癌骨转移的预后进行观察,旨在探讨肺癌骨转移的特点和规律。结果:骨转移单发者占26.2％,多发者占73.8％。腺癌平均每例发生骨转移1.95处,鳞癌平均每例发生骨转移1.61处。腺癌以胸部及骨盆转移为主,鳞癌以胸部及脊柱转移为主。x线摄片检出31.5％,CT骨扫描为38.5％,MRI为75％,ECT为100％。死亡者平均存活6.3个月。提示:肺癌骨转移以多发者多见,腺癌骨转移率最高,鳞癌次之。转移部位以胸部最多,其次为骨盆和脊柱。ECT对骨转移的诊断最有价值。骨转移为肺癌预后不良的因素之一。
This paper analyzes the relationship between 42 patients with bone metastases from lung cancer and their different pathological types, and observes the prognosis of bone metastasis of lung cancer in order to investigate the characteristics and regularity of bone metastasis of lung cancer. Results: 26.2% of patients with bone metastases were single, and 73.8% were multiple. The average incidence of bone metastases was 1.95 in each case of adenocarcinoma, and there were 1.61 bone metastases in each case. Adenocarcinoma is mainly metastasized to the chest and pelvis, and squamous cell carcinoma is mainly metastasized to the chest and spine. 31.5% were detected on the radiograph, 38.5% on the CT scan, 75% on the MRI, and 100% on the ECT. The average number of survivors was 6.3 months. Tip: The incidence of bone metastases from lung cancer is more common in patients with multiple metastases, with the highest rate of bone metastases in adenocarcinoma, followed by squamous cell carcinoma. The site of metastasis was the largest in the chest, followed by the pelvis and spine. ECT is most valuable in the diagnosis of bone metastases. Bone metastasis is one of the factors of poor prognosis of lung cancer.